LLY

783.6

-1.64%↓

JNJ

152.55

-0.11%↓

ABBV

186.51

-1.24%↓

NVO

68.55

+1.24%↑

UNH

305.58

+0.32%↑

LLY

783.6

-1.64%↓

JNJ

152.55

-0.11%↓

ABBV

186.51

-1.24%↓

NVO

68.55

+1.24%↑

UNH

305.58

+0.32%↑

LLY

783.6

-1.64%↓

JNJ

152.55

-0.11%↓

ABBV

186.51

-1.24%↓

NVO

68.55

+1.24%↑

UNH

305.58

+0.32%↑

LLY

783.6

-1.64%↓

JNJ

152.55

-0.11%↓

ABBV

186.51

-1.24%↓

NVO

68.55

+1.24%↑

UNH

305.58

+0.32%↑

LLY

783.6

-1.64%↓

JNJ

152.55

-0.11%↓

ABBV

186.51

-1.24%↓

NVO

68.55

+1.24%↑

UNH

305.58

+0.32%↑

Search

Champions Oncology Inc

Ouvert

SecteurSoins de santé

7.21 3

Résumé

Variation du prix de l'action

24h

Actuel

Min

6.73

Max

7.44

Chiffres clés

By Trading Economics

Revenu

3.8M

4.5M

Ventes

3.6M

17M

P/E

Moyenne du Secteur

17.911

50.291

BPA

0.33

Marge bénéficiaire

26.381

Employés

210

EBITDA

3.8M

4.9M

Dividendes

By Dow Jones

Prochains Résultats

10 sept. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-23M

111M

Ouverture précédente

4.21

Clôture précédente

7.21

Sentiment de l'Actualité

By Acuity

50%

50%

154 / 380 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bearish Evidence

Champions Oncology Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

11 déc. 2024, 23:55 UTC

Actions en Tendance

Stocks to Watch: Adobe, Champions Oncology, DBV Technologies

Comparaison

Variation de prix

Champions Oncology Inc prévision

Note du Consensus

By TipRanks

0 ratings

0

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

5.77 / 7.61Support & Résistance

Court Terme

Bearish Evidence

Moyen Terme

Very Strong Bearish Evidence

Long Terme

Strong Bearish Evidence

Sentiment

By Acuity

154 / 380Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.